BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9241133)

  • 1. Preventing glucocorticoid-induced osteoporosis.
    Reid IR
    N Engl J Med; 1997 Aug; 337(6):420-1. PubMed ID: 9241133
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
    Adachi JD; Bensen WG; Brown J; Hanley D; Hodsman A; Josse R; Kendler DL; Lentle B; Olszynski W; Ste-Marie LG; Tenenhouse A; Chines AA
    N Engl J Med; 1997 Aug; 337(6):382-7. PubMed ID: 9241127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etidronate and glucocorticoid induced osteoporosis.
    Ortego-Centeno N; Muñoz-Torres M; Callejas-Rubio JL; Riera-Montes M
    J Rheumatol; 2005 Jan; 32(1):199-200. PubMed ID: 15630758
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M; Gradowska L; Marcinowska-Suchowierska E; Durlik M; Gaciong Z; Lao M
    Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract]   [Full Text] [Related]  

  • 5. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
    Adachi JD; Roux C; Pitt PI; Cooper C; Moniz C; Dequeker J; Ioannidis G; Cawley MI; Jenkins EA; Walker-Bone KE; Pack S; Stephenson GF; Laan RF; Brown J; Geusens P
    J Rheumatol; 2000 Oct; 27(10):2424-31. PubMed ID: 11036840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S; Ohosone Y; Suwa A; Yasuoka H; Nojima T; Fujii T; Kuwana M; Nakamura K; Mimori T; Hirakata M
    J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM; Hillner BE
    J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
    Saag KG; Emkey R; Schnitzer TJ; Brown JP; Hawkins F; Goemaere S; Thamsborg G; Liberman UA; Delmas PD; Malice MP; Czachur M; Daifotis AG
    N Engl J Med; 1998 Jul; 339(5):292-9. PubMed ID: 9682041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
    Nakayama H
    Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucocorticoid induced osteoporosis].
    Lange U; Müller-Ladner U
    Orthopade; 2007 Apr; 36(4):381-8; quiz 389-90. PubMed ID: 17665509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD; Papaioannou A
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Asthma--prevention of glucocorticoid-induced osteoporosis with etidronate and calcium].
    Pneumologie; 2005 Feb; 59(2):94. PubMed ID: 15724219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concurrent treatment of osteoporosis including vitamin K].
    Kobayashi S; Shiraki M; Takaoka K
    Clin Calcium; 2007 Nov; 17(11):1731-7. PubMed ID: 17982194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
    Soen S
    Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence and utility of etidronate for the treatment of osteoporosis].
    Takada J; Iba K; Yamashita T; Yoshizaki T
    Clin Calcium; 2008 Oct; 18(10):1427-33. PubMed ID: 18830039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoporosis management in general practice. Preventing spontaneous bone fractures].
    MMW Fortschr Med; 2010 Jul; 152(25-27):54-5. PubMed ID: 20672666
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].
    Vestergaard P; Laursen LC; Schwarz P; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):898-900. PubMed ID: 15789844
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.